Neurovascular Devices Market Size and Forecast 2031

Neurovascular Devices Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Neurothrombectomy Devices, Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, and Support Devices), Application (Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Specialized Clinics), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPHE100000781
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

The neurovascular devices market size in 2021 stood at US$ 3.22 billion and is projected to reach US$ 5.79 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 6.2% in 2023–2031. Growing ongoing clinical trials and rising prevalence in the cases of stroke in developed as well as developing economies are likely to remain key neurovascular devices market trends.

Neurovascular Devices Market Analysis

Advanced imaging techniques and minimally invasive procedures have enabled healthcare professionals to perform more precise and less invasive procedures, ultimately reducing the risks associated with traditional surgical approaches. The increasing prevalence of neurological diseases is one of the critical factors driving the neurovascular devices market growth. Factors such as an aging people and modifying lifestyle changes have led to an increased incidence of diseases such as stroke and cerebral aneurysms, further highlighting the need for neurovascular interventions. Furthermore, there has been a substantial shift toward minimally invasive techniques and devices, thereby reducing the invasiveness of the neurovascular procedures. This shift has resulted in shorter hospital stays, faster recovery times, and lower patient healthcare costs, making these procedures more accessible and attractive to patients and healthcare providers. These technological and medical advances have collectively contributed to the impressive growth of the neurovascular device market and improved patient care and outcomes.

Neurovascular Devices Market Overview

Neurovascular devices treat diseases of the blood arteries that supply oxygen-rich blood to the brain. For a complex aneurysm, neurovascular thrombectomy devices are used to remove the clot that caused the stroke. Many endovascular devices, such as snares, vacuum cleaners, and blood clot extraction devices, fall into this category. The market is expanding for many reasons, such as the rapid pace of technical innovation in this sector. Neurovascular devices include stenting systems, embolization devices, and neurothrombectomy devices used to treat neurovascular diseases such as brain aneurysms. The increasing prevalence of these diseases in the population and increasing government initiatives to raise awareness of treatment options are expected to drive product demand to treat these diseases.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Neurovascular Devices Market: Strategic Insights

Neurovascular Devices Market

  • CAGR (2023 - 2031)
  • Market Size 2021
    US$ 3.22 Billion
  • Market Size 2031
    US$ 5.79 Billion

Market Dynamics

  • Increasing Incidences of Neurovascular Diseases
  • Rising Demand for Minimally Invasive Procedures
  • Significantly Growing Aging Population
  • Enduring Clinical Trials for the Treatment of Stroke
  • Development in the Healthcare Market
  • Lack of Expert Professionals

Key Players

  • Medtronic plc,
  • Stryker Corporation.,
  • Johnson & Johnson Services, Inc.,
  • Acandis GmbH & Co. KG.,
  • MicroPort Scientific Corporation,
  • Terumo Corporation,
  • Penumbra, Inc.,
  • phenox GmbH,
  • Integer Holdings Corporation,
  • Memry Corporation

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

  • Neurothrombectomy Devices
  • Aneurysm Coiling & Embolization Devices
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Support Devices
  • Cerebral Aneurysms
  • Ischemic Strokes
  • Arteriovenous Malformation & Fistulas
  • Others
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Neurovascular Devices Market Drivers and Opportunities

Rising Demand for Minimally Invasive Procedures to Favor Market

Minimally invasive surgeries are seeing high adoption due to their cosmetic appeal and shorter recovery times, which could further streamline the market expansion of neurovascular devices. Surgical procedures have continually introduced innovations and improvements to make them safer for patients. Minimally invasive surgery has become the standard for surgical procedures traditionally performed using an open technique. These surgical procedures include laparoscopic surgery, endoscopic surgery, and robotic surgery. The increased demand for minimally invasive neurosurgical procedures, the increasing knowledge of neurosurgeons about minimally invasive procedures, and the increase in research studies in the field of neurovascular therapy may provide lucrative opportunities for key competitors in the coming period. Such scenarios are expected to favor the industry landscape.

Increasing Growth Strategies– An Opportunity for Neurovascular Devices Market Growth

Increasing organic growth strategies, such as product approvals from regulatory authorities to expand product portfolios of key players, are projected to drive market growth. For example, Scientia Vascular, a US-based medical device company, announced in May 2021 that it had received $50 million in funding from Vivo Capital, a healthcare investment firm, to develop guidewires and microcatheters to treat stroke. Innovative technologies will continue to expand the range of neurovascular tools available to treat various types of aneurysms more safely and efficiently. Aneurysm management constantly evolves, with sophisticated technology at the forefront of innovation.

Neurovascular Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the neurovascular devices market analysis are product, application, and end user.

  • Based on product, the neurovascular devices market is divided into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, and support devices. In 2023, aneurysm coiling & embolization devices segment held the largest share of the market, and the same segment is anticipated to register the highest CAGR during the forecast period. The segment is further categorized into embolic coils, bare detachable coils, coated detachable coils, flow diversion devices, and liquid embolic agents.
  • By application, the market is segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and others. In 2023, ischemic strokes segment held the largest share of the market, and the same segment is anticipated to register the highest CAGR during 2023–2031.
  • In terms of end user, the market is segmented into hospitals, ambulatory surgical centers, and specialized clinics. In 2023, hospitals segment held the largest share of the market, and the same segment is estimated to register the highest CAGR during the forecast period. The hospital segment is expected to grow at the fastest rate during the coming year owing to the availability of better healthcare facilities as well as reimbursement policies from government bodies.

Neurovascular Devices Market Share Analysis by Geography

The geographic scope of the neurovascular devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the neurovascular devices market. The growth of the market in North America is attributed to the increasing prevalence of various neurological diseases and higher diagnosis and treatment rates. Additionally, increasing healthcare spending to support neurological care in the region and adequate reimbursement for various neurological diseases will encourage the introduction of advanced, novel treatment options. For example, private and public health insurers such as Medicare, Medicaid, and others offer favourable reimbursement policies for neurovascular products, including all embolic and fluid coils. Furthermore, technological advancements and increasing research and development activities leading to product launches and approvals, as well as partnerships and acquisitions by key players, contribute to the market's growth. For example, in July 2022, Rapid Medical, a developer of advanced neurovascular devices, received FDA 510(k) clearance for TIGERTRIEVER for the treatment of large vessel occlusions at the Society of Neurointerventional Surgery (SNIS) 2022 Annual Meeting in Toronto. The device is one of the smallest revascularization devices used to remove thrombi from delicate brain blood vessels during an ischemic stroke. These developments are expected to drive market growth in the region over the forecast period as they offer a less traumatic approach than existing devices. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Neurovascular Devices Market News and Recent Developments

The neurovascular devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for neurovascular devices:

  • Medtronic received CE Mark for Evolut FX TAVI System for treatment of severe aortic stenosis. The transcatheter aortic valve implantation (TAVI) system, the newest-generation TAVI system of the CoreValveTM/Evolut TAVI platform. (Medtronic, Press Release, 2023)
  • Stryker announced that it completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular’s CE Marked products, the Contour Neurovascular System, and the Neqstent Coil Assisted Flow Diverter, will expand Stryker’s current portfolio of aneurysm treatment solutions. (Stryker, News, 2023)
  • ASAHI INTECC CO., LTD. announced that they have concluded a contract with Sensome SAS (“Sensome”), a French medical device company, for a development and manufacturing partnership of a next-generation smart stroke guidewire. (ASAHI INTECC CO., LTD., News, 2023)
  • Stryker launched a state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation in Asia Pacific. (Stryker, News, 2022)
  • Genesis MedTech Group reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which entered into strategic cooperation with Penumbra, Inc., for the domestic sales and production of products with Penumbra's technology for the Chinese market. (Genesis Medtech, News, 2021)

Neurovascular Devices Market Report Coverage and Deliverables

The “Neurovascular Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Neurovascular Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3.22 Billion
Market Size by 2031 US$ 5.79 Billion
Global CAGR (2023 - 2031) 6.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Neurothrombectomy Devices
  • Aneurysm Coiling & Embolization Devices
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Support Devices
By Application
  • Cerebral Aneurysms
  • Ischemic Strokes
  • Arteriovenous Malformation & Fistulas
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic plc,
  • Stryker Corporation.,
  • Johnson & Johnson Services, Inc.,
  • Acandis GmbH & Co. KG.,
  • MicroPort Scientific Corporation,
  • Terumo Corporation,
  • Penumbra, Inc.,
  • phenox GmbH,
  • Integer Holdings Corporation,
  • Memry Corporation
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Product , Application ; and End User and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Neurovascular Devices Market